Last updated: June 5, 2026

Back to directory

SkinVision medical AI product profile

AI-powered skin cancer detection app that provides a risk assessment for uploaded skin spots and is CE-certified under EU MDR Class IIa.

Screenshot of the official SkinVision product page
Patient access, triage, and agents

Best fit

Access programs that want consumer skin-check guidance with clear escalation to clinicians and strict messaging that the app does not diagnose.

Primary use case
Consumer-facing AI skin spot risk assessment, skin cancer awareness, and guidance on when to seek medical review
Audience
Patients, payers, digital front-door teams, population health programs, and dermatology access teams evaluating skin-check navigation
Risk level
Medium to high
Pricing signal
Consumer subscription, insurer, and partner access vary by country; verify current plan, reimbursement, and regional availability.
Official sources
4 official sources

Compare within workflow: Patient access, triage, and agents · comparison shortlist · source index

Regulatory, privacy, evidence, and workflow lens

Product-specific review. These product-specific signals summarize what the cited sources imply before treating SkinVision as safe for a local clinical, operational, or research workflow.

Regulatory / FDAConfirm country availability, EU MDR certification, medical-device status, patient-facing claims, and whether local deployment creates additional clinical or payer obligations.
PrivacyReview photo upload, encryption, deletion, dermatologist review, account data, insurer or partner data sharing, consent, retention, and cross-border processing before recommending use.
EvidenceReview published validation and monitor false reassurance, missed malignancy, skin-tone performance, image quality, user adherence, and escalation completion.
WorkflowBest governed as access and awareness support with clear safety-net language, clinician referral paths, no diagnostic substitution, and review of high-risk or uncertain results.

Where SkinVision fits

SkinVision describes a CE-certified EU MDR Class IIa medical device app that uses AI and dermatologist oversight to provide low or high risk indications for skin spots; help materials state that Smart Check is trained and validated by dermatologists, supports melanoma, BCC, SCC, and actinic keratosis risk assessment, and provides guidance rather than diagnosis.

Not for: Emergency evaluation, definitive diagnosis, replacing a clinician or biopsy, unsupported countries, or patient-facing reassurance without safety-net instructions.

What to verify before using SkinVision

Source links

Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.

Related medical AI products